Page last updated: 2024-11-08

7-hydroxyamoxapine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

7-hydroxyamoxapine: metabolite of amoxapine [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID162242
CHEBI ID143288
SCHEMBL ID142222
MeSH IDM0124080

Synonyms (18)

Synonym
7-hydroxyamoxapine
2-chloro-11-(1-piperazinyl)dibenzo[b,f][1,4]oxazepin-7-ol
7-hydroxyamoxapin
2-chloro-11-(1-piperazinyl)-dibenz[b,f][1,4]oxazepin-7-ol
7-hydroxy amoxapine
FT-0669311
CHEBI:143288
8-chloro-6-piperazin-1-ylbenzo[b][1,4]benzoxazepin-2-ol
9z11f654nr ,
dibenz(b,f)(1,4)oxazepin-7-ol, 2-chloro-11-(1-piperazinyl)-
37081-76-8
unii-9z11f654nr
SCHEMBL142222
2-chloro-11-(1-piperazinyl)dibenzo[b,f][1,4]oxazepin-7-ol #
MEUGUMOVYNSGEW-UHFFFAOYSA-N
DTXSID00190576
AKOS030254514
Q4642870

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
dibenzooxazepineAn organic heterotricyclic compound consisting of two benzene rings fused to a seven-membered ring containing one oxygen and one nitrogen atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (55.56)18.7374
1990's2 (22.22)18.2507
2000's0 (0.00)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.79 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.19 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.79)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (11.11%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]